Kyle Carter

Kyle Carter has a diverse work experience that spans multiple fields. Kyle started their career as an Undergraduate Research Assistant at Western Washington University, where they conducted research on marine alarm pheromones. Kyle then completed a PhD at the University of Colorado Boulder, where they worked as a Graduate Research Assistant and focused on engineering metal ion sensors and manipulating sub-cellular metal concentrations. During their time at Colorado, they also served as a Teaching Assistant for a general chemistry course.

Following their PhD, Kyle joined Novartis Institutes for BioMedical Research as an Intern, where they characterized the protein target of a novel drug lead. Kyle then moved on to Stanford University, where they worked as a Postdoctoral Researcher under the mentorship of Dr. Polly Fordyce. During their time at Stanford, they developed microfluidic tools for enzymology and protein stability assays, as well as optimized methods for mutant library generation.

Currently, Kyle is working at GigaGen Inc. Kyle started as a Senior Scientist and eventually transitioned into the role of Associate Director of Technology Development. However, specific details about their responsibilities and achievements in these roles are not provided.

Kyle Carter completed their education in the field of Biochemistry. Kyle obtained a Doctor of Philosophy (PhD) degree from the University of Colorado Boulder, where they studied from 2011 to 2017. Prior to that, they completed a Bachelor of Science (BS) degree in Biochemistry at Western Washington University, where they studied from 2007 to 2011. In addition to their formal education, Kyle Carter also has a certification from EMBL (European Molecular Biology Laboratory) for attending the Microfluidics Conference in July 2022.